Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects

Michael T. Halpern, David W. Covert, Alan L. Robin, M. Bruce Shields, Allan J. Flach, Robert L. Stamper

Research output: Contribution to journal › Conference article › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects'. Together they form a unique fingerprint.

Medicine & Life Sciences